{"nct_id":"NCT04095793","title":"Phase 3 Open-Label Extension Study of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure","status":"TERMINATED","status_verified_date":"2022-11","start_date":"2019-09-19","start_date_type":"ACTUAL","primary_completion_date":"2021-11-12","primary_completion_date_type":"ACTUAL","completion_date":"2021-11-12","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["TBPH"]}